Mazo A - Search Results

1

Adenoviral-mediated overexpression of human equilibrative nucleoside transporter 1 (hENT1) enhances gemcitabine response in human pancreatic cancer.

Pérez-Torras S, García-Manteiga J, Mercadé E, Casado FJ, Carbó N, Pastor-Anglada M, Mazo A. Pérez-Torras S, et al. Among authors: mazo a. Biochem Pharmacol. 2008 Aug 1;76(3):322-9. doi: 10.1016/j.bcp.2008.05.011. Epub 2008 May 20. Biochem Pharmacol. 2008. PMID: 18589402

2

Nucleoside transporter profiles in human pancreatic cancer cells: role of hCNT1 in 2',2'-difluorodeoxycytidine- induced cytotoxicity.

García-Manteiga J, Molina-Arcas M, Casado FJ, Mazo A, Pastor-Anglada M. García-Manteiga J, et al. Among authors: mazo a. Clin Cancer Res. 2003 Oct 15;9(13):5000-8. Clin Cancer Res. 2003. PMID: 14581375

3

Adenovirus-mediated retinoblastoma 94 gene transfer induces human pancreatic tumor regression in a mouse xenograft model.

Roig JM, Molina MA, Cascante A, Calbó J, Carbó N, Wirtz U, Sreedharan S, Fillat C, Mazo A. Roig JM, et al. Among authors: mazo a. Clin Cancer Res. 2004 Feb 15;10(4):1454-62. doi: 10.1158/1078-0432.ccr-0442-03. Clin Cancer Res. 2004. PMID: 14977849

4

Enhancement of gemcitabine-induced apoptosis by restoration of p53 function in human pancreatic tumors.

Cascalló M, Calbó J, Capellà G, Fillat C, Pastor-Anglada M, Mazo A. Cascalló M, et al. Among authors: mazo a. Oncology. 2005;68(2-3):179-89. doi: 10.1159/000086772. Epub 2005 Jul 4. Oncology. 2005. PMID: 16006755

5

Connexin-26 is a key factor mediating gemcitabine bystander effect.

Garcia-Rodríguez L, Pérez-Torras S, Carrió M, Cascante A, García-Ribas I, Mazo A, Fillat C. Garcia-Rodríguez L, et al. Among authors: mazo a. Mol Cancer Ther. 2011 Mar;10(3):505-17. doi: 10.1158/1535-7163.MCT-10-0693. Mol Cancer Ther. 2011. PMID: 21388975

6

Characterization of human pancreatic orthotopic tumor xenografts suitable for drug screening.

Pérez-Torras S, Vidal-Pla A, Miquel R, Almendro V, Fernández-Cruz L, Navarro S, Maurel J, Carbó N, Gascón P, Mazo A. Pérez-Torras S, et al. Among authors: mazo a. Cell Oncol (Dordr). 2011 Dec;34(6):511-21. doi: 10.1007/s13402-011-0049-1. Epub 2011 Jun 17. Cell Oncol (Dordr). 2011. PMID: 21681527 Free article.

7

Human pancreatic cancer stem cells are sensitive to dual inhibition of IGF-IR and ErbB receptors.

Urtasun N, Vidal-Pla A, Pérez-Torras S, Mazo A. Urtasun N, et al. Among authors: mazo a. BMC Cancer. 2015 Apr 4;15:223. doi: 10.1186/s12885-015-1249-2. BMC Cancer. 2015. PMID: 25886138 Free PMC article.

8

Pharmacogenomic analyzis of the responsiveness of gastrointestinal tumor cell lines to drug therapy: A transportome approach.

Grañé-Boladeras N, Pérez-Torras S, Lozano JJ, Romero MR, Mazo A, Marín JJG, Pastor-Anglada M. Grañé-Boladeras N, et al. Among authors: mazo a. Pharmacol Res. 2016 Nov;113(Pt A):364-375. doi: 10.1016/j.phrs.2016.09.007. Epub 2016 Sep 9. Pharmacol Res. 2016. PMID: 27620070

9

Treatment based on a combination of the CYP2B1/cyclophosphamide system and p53 delivery enhances tumour regression in human pancreatic cancer.

Mercadé E, Cascalló M, Carrió M, Calbó J, Gómez-Treviño A, Fillat C, Gómez-Foix AM, Mazo A. Mercadé E, et al. Among authors: mazo a. Ann Oncol. 2001 Mar;12(3):379-88. doi: 10.1023/a:1011177223129. Ann Oncol. 2001. PMID: 11332152 Free article.

10

Dual effects of β3 integrin subunit expression on human pancreatic cancer models.

Marchán S, Pérez-Torras S, Vidal A, Adan J, Mitjans F, Carbó N, Mazo A. Marchán S, et al. Among authors: mazo a. Anal Cell Pathol (Amst). 2010;33(5):191-205. doi: 10.3233/ACP-CLO-2010-0538. Anal Cell Pathol (Amst). 2010. PMID: 20978323 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters